According to Acasti Pharma 's latest financial reports the company's current earnings (TTM) are -$48.59 M. a decrease over its 2022 earnings that were of -$18.57 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$48.59 M | 161.72% |
2022 | -$18.57 M | 60.58% |
2021 | -$11.57 M | -462.11% |
2020 | $3.19 M | |
2018 | -$25.15 M | |
2016 | -$5.56 M | 36.44% |
2015 | -$4.08 M | 190.58% |
2014 | -$1.41 M | -85.85% |
2013 | -$9.91 M | 49.28% |
2012 | -$6.64 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Omeros Corporation OMER | -$0.15 B | 208.71% | ๐บ๐ธ USA |